Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer
出版年份 2016 全文链接
标题
Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer
作者
关键词
Cytokine-induced killer cells, Immunotherapy, Pancreatic cancer, Overall survival
出版物
Journal of Hematology & Oncology
Volume 9, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-02-03
DOI
10.1186/s13045-016-0237-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Myeloid-derived suppressor cell impact on endogenous and adoptively transferred T cells
- (2015) Ainhoa Arina et al. CURRENT OPINION IN IMMUNOLOGY
- Progress in the Treatment of Metastatic Pancreatic Cancer and the Search for Next Opportunities
- (2015) Andrew H. Ko JOURNAL OF CLINICAL ONCOLOGY
- Advances in the management of gastrointestinal cancers—an upcoming role of immune checkpoint blockade
- (2015) Gaurav Goel et al. Journal of Hematology & Oncology
- Nivolumab plus ipilimumab in the treatment of advanced melanoma
- (2015) Katy K. Tsai et al. Journal of Hematology & Oncology
- Programmed death 1 blockade, an Achilles heel for MMR-deficient tumors?
- (2015) Andy Yingjie Lin et al. Journal of Hematology & Oncology
- Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the future
- (2015) Gaurav Goel et al. Journal of Hematology & Oncology
- Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer
- (2014) Moon Jae Chung et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Adverse Immunoregulatory Effects of 5FU and CPT11 Chemotherapy on Myeloid-Derived Suppressor Cells and Colorectal Cancer Outcomes
- (2014) J. Kanterman et al. CANCER RESEARCH
- Clinical Activity of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Post-Mastectomy Triple-Negative Breast Cancer
- (2014) K. Pan et al. CLINICAL CANCER RESEARCH
- Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC)
- (2014) Leonard Christopher Schmeel et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma
- (2013) Tomar Ghansah et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Increased CD14+HLA-DR-/low myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients
- (2013) Ang Huang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cytokine-Induced Killer Cells Eradicate Bone and Soft-Tissue Sarcomas
- (2013) D. Sangiolo et al. CANCER RESEARCH
- Effective Activity of Cytokine-Induced Killer Cells against Autologous Metastatic Melanoma Including Cells with Stemness Features
- (2013) L. Gammaitoni et al. CLINICAL CANCER RESEARCH
- Association of Myeloid-derived Suppressor Cells and Efficacy of Cytokine-induced Killer Cell Immunotherapy in Metastatic Renal Cell Carcinoma Patients
- (2013) Zibing Wang et al. JOURNAL OF IMMUNOTHERAPY
- S-1 plus CIK as second-line treatment for advanced pancreatic cancer
- (2013) Meng Wang et al. MEDICAL ONCOLOGY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Autologous Cytokine-induced Killer Cell Transfusion in Combination With Gemcitabine Plus Cisplatin Regimen Chemotherapy for Metastatic Nasopharyngeal Carcinoma
- (2012) Jian-jun Li et al. JOURNAL OF IMMUNOTHERAPY
- 5-Fluorouracil and Interferon-α Immunochemotherapy Enhances Immunogenicity of Murine Pancreatic Cancer Through Upregulation of NKG2D Ligands and MHC Class I
- (2012) Hadeel Khallouf et al. JOURNAL OF IMMUNOTHERAPY
- Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity
- (2011) A. Pievani et al. BLOOD
- Differential Expression of MicroRNAs in CD34+ Cells of 5q- Syndrome
- (2011) Hana Votavova et al. Journal of Hematology & Oncology
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced killing of human B-cell lymphoma targets by combined use of cytokine-induced killer cell (CIK) cultures and anti-CD20 antibodies
- (2010) A. Pievani et al. BLOOD
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
- (2010) J. Vincent et al. CANCER RESEARCH
- Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study
- (2010) Giuseppe Colucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice
- (2009) Hanh K. Le et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Long term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysis
- (2009) Bernardo HL Goulart et al. Journal of Hematology & Oncology
- In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity
- (2008) R. Nishimura et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now